Aptargroup - ATR STOCK NEWS

Aptar, a global leader in drug delivery and consumer product dispensing technologies, has been named one of America's Climate Leaders 2024 by USA Today for the second consecutive year. The company has showcased significant advancements in sustainability, including a climate transition plan aligned with the latest climate science, and achieving 97% of its electricity consumption from renewable sources by the end of 2023. Additionally, Aptar has reduced its absolute Scope 1 and Scope 2 emissions by 77% since 2019, and has seen a year-over-year reduction in Scope 3 emissions. The company was also recognized among America’s Most Responsible Companies 2024 by Newsweek and one of Barron’s 100 Most Sustainable U.S. Companies. These achievements are highlighted in their 2023 Corporate Sustainability/ESG Report, which adheres to GRI Standards.

Aptar has released its 2023 Corporate Sustainability and ESG Report, titled Progress Takes Shape. The report outlines significant accomplishments in the company's sustainability strategy, focusing on three main pillars: Care, Collaboration, and Circularity.

Key achievements include sourcing 97% of electricity from renewable sources, preventing 86% of operational waste from reaching landfills, and obtaining Landfill Free Certification for 63% of its sites. Aptar has also earned the EcoVadis Platinum rating and the CDP Supplier Engagement Leader status for the fourth consecutive year.

Additionally, Aptar has partnered with organizations like the Ellen MacArthur Foundation and the World Business Council for Sustainable Development. The company's Diversity, Equity, and Inclusion (DEI) initiatives have led to 25.4% female leadership at the VP level and above, with a goal of reaching 30% by 2025.

Aptar continues to support communities through donations, local charitable events, and global campaigns for women's economic empowerment.

Aptar, a leader in drug and consumer product technologies, has achieved a Platinum rating from EcoVadis for the fourth consecutive year, placing it in the top 1% of more than 125,000 companies rated globally. This recognition highlights Aptar's commitment to sustainability, encompassing eco-efficient operations, renewable energy sourcing, and the development of recyclable and reusable products. The EcoVadis assessment evaluates companies on environment, labor and human rights, ethics, and sustainable procurement. Aptar integrates these principles into its Supplier Screening Program, enhancing transparency and continuous improvement. The firm's sustainability efforts are further recognized by affiliations with the United Nations Global Compact and the Ellen MacArthur Foundation.

AptarGroup, Inc. (NYSE:ATR) reported strong first quarter results with a 6% increase in sales, net income up by 52%, and earnings per share rising by 50%. The Pharma segment saw a 14% sales growth, Beauty segment remained steady, and Closures segment increased by 2%. The company's outlook for 2024 is positive, expecting growth in drug delivery systems and consumer dispensing technologies.

AptarGroup, Inc. (NYSE: ATR) announces a quarterly cash dividend of $0.41 per share and a conference call to discuss first quarter results for 2024.

AptarGroup, Inc. (NYSE: ATR) has been recognized for its emissions reductions efforts and named to the CDP Supplier Engagement Leaderboard for the fourth consecutive year. Aptar received an 'A' supplier engagement rating, surpassing the global and sector averages. The company collaborates with suppliers to reduce emissions and promote sustainability, with a focus on environmentally conscious supply chain practices.

AptarGroup, Inc. (NYSE: ATR) has been named one of Barron’s 100 Most Sustainable U.S. Companies for the sixth consecutive year, ranking 29th for 2024. The company's commitment to sustainability is evident through various achievements and recognitions, including a Platinum level rating from EcoVadis, significant progress in emissions reduction, and eco-design initiatives.

Aptar Digital Health, a part of AptarGroup, Inc., has entered into an enterprise agreement with Biogen Inc. to develop digital health solutions for neurological and rare diseases globally. The collaboration will cover several indications in neurology and immunology across 15 countries, focusing on providing advanced digital solutions for disease management.

AptarGroup, Inc. (NYSE:ATR) reported strong fourth quarter operational results, with a 5% increase in sales and a 6% increase in net income. The company achieved double-digit growth in its proprietary drug delivery systems and fragrance dispensing technologies. The Pharma segment had an exceptional year with over 20% core sales growth in the fourth quarter, while the beauty dispensing solutions in fragrance also delivered double-digit core sales growth for 2023. The company's focus on cost management and operational leverage yielded margin expansion for each segment compared to the prior year. Tanda, President and CEO, expressed optimism for continued solid growth in 2024.